Spandow Oliver J. 4
4 · NEPHROS INC · Filed Dec 16, 2021
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Spandow Oliver J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-14+7,062→ 7,062 totalExercise: $6.82Exp: 2031-12-14→ Common Stock (7,062 underlying) - Award
Common Stock
2021-12-14+5,429→ 24,829 total
Holdings
- 9,466
Stock Option (Right to Buy)
Exercise: $5.58Exp: 2028-08-10→ Common Stock (9,466 underlying) - 6,850
Stock Option (Right to Buy)
Exercise: $8.06Exp: 2031-01-06→ Common Stock (6,850 underlying) - 5,568
Stock Option (Right to Buy)
Exercise: $8.57Exp: 2029-12-16→ Common Stock (5,568 underlying) - 5,161
Stock Option (Right to Buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (5,161 underlying)
Footnotes (4)
- [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
- [F2]Fully exercisable.
- [F3]This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.
- [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.